Sr. Principal Process Engineer - Small Molecule (NOT REMOTE - NEW SITE) at Eli Lilly and Company

Chester, Maryland, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Process EngineeringSmall Molecule ManufacturingPeptide ManufacturingAPI ManufacturingGMPRoot Cause AnalysisStatistical MethodsFirst Principles

Questions & Answers

Common questions about this position

Is this position remote?

No, this position is not remote and requires on-site work at the new manufacturing site.

What are the basic qualifications for this role?

Candidates need a Bachelor's Degree in Process, Chemical, Biochemical Engineering or related applicable STEM discipline, plus 5+ years of experience in API Manufacturing Unit Operations.

What additional experience is preferred for this position?

Preferred experience includes API chemical synthesis and biotech unit operations like chromatography, understanding of GMP production environments, and strong technical foundations.

What is the company culture like at Eli Lilly?

Eli Lilly emphasizes uniting caring with discovery, putting people first, and building a culture to enable successful startup into GMP manufacturing operations at the new site.

What makes a strong candidate for this Senior Principal Process Engineer role?

Strong candidates will have the required degree and 5+ years in API manufacturing, plus preferred experience in chemical synthesis, chromatography, GMP environments, and the ability to provide technical leadership while mentoring engineers during site startup.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI